Puma Biotechnology reported $370.52M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 19.93B 3.36B
Amgen AMGN:US $ 140.05B 3.22B
Arena Pharmaceuticals ARNA:US $ 4.16B 41.38M
Array Technologies Inc ARRY:US 1.98B 1.81B
Biogen BIIB:US $ 52.13B 9.52B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Bluebird Bio BLUE:US $ 2.16B 132.67M
Cerulean Pharma CERU:US $ 93.27M 13.31M
Clovis Oncology CLVS:US $ 606.48M 127.32M
Daiichi Sankyo 4568:JP 4662.17B 2197.51B
Esperion Therapeutics ESPR:US $ 596.26M 193.51M
Exelixis EXEL:US $ 5.71B 1.36B
Gilead Sciences GILD:US $ 86.36B 4.99B
Glaxosmithkline GSK:US 98.75B 9.46B
Intercept Pharmaceuticals ICPT:US $ 663.03M 98.97M
Macrogenics MGNX:US $ 1.62B 176.65M
Mirati Therapeutics MRTX:US $ 8.31B 483.81M
Moderna Inc MRNA:US $ 94.35B 41.95B
Novartis NOVN:VX 208.02B 8.76B
Pfizer PFE:US $ 219205.69M 17108.81M
Ptc Therapeutics PTCT:US $ 2.98B 347.22M
Puma Biotechnology PBYI:US $ 370.52M 20.79M
Regeneron Pharmaceuticals REGN:US $ 59.5B 8.81B
Sangamo Biosciences SGMO:US $ 1.72B 78.47M
Sarepta Therapeutics SRPT:US $ 6.2B 282.45M
Seattle Genetics SGEN:US $ 28.65B 3.48B
Spectrum Pharmaceuticals SPPI:US $ 615.4M 114.24M
Takeda 4502:JP 5869.99B 411.92B
Tg Therapeutics TGTX:US $ 5.51B 1.27B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Vanda Pharmaceuticals VNDA:US $ 1.2B 370.85M
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B
YTE INCY:US $ 18.5B 632.77M